<i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer
<i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer is a paper indexed in PICO Portal from OpenAlex.
How many citations does <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer have?
<i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer has 116 citations in the OpenAlex counts PICO Portal stores.
When was <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer published?
<i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer has 2020 year in the PICO Portal index.
What is the open-access status of <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer?
<i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer has gold oa status in the PICO Portal index.
What is the DOI of <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer?
The DOI for <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer is on the source record.
What is the PMID of <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer?
The PMID for <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer is on the source record.
What is the OpenAlex record for <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer?
The OpenAlex for <i>MUC4</i>, <i>MUC16</i>, and <i>TTN</i> genes mutation correlated with prognosis, and predicted tumor mutation burden and immunotherapy efficacy in gastric cancer and pan‐cancer is on the source record.